-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
- Cosmetic Ingredient
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
Unqualified Chinese herbs and drink tablets (8 batches): bamboo, masturbation, small grass, Qin , flat shellfish, red flowers (2 batches), big dragonflies.
Non-conforming solid preparations (10 batches): vitamin C calcium capsules, psychic capsules (2 batches), zinc sulfate tablets, cold and hot particles, compound dansin tablets, compound wearing heart lotus tablets (2 batches), octa-Jinyi mother pills, aspirin intestinal solution tablets do not meet the requirements of the project: characteristics, examination, content determination.
the small editor noted that five batches were produced in 2020, meaning that the five batches would be punished under the new drug administration law.
In order to strengthen drug quality supervision and ensure the safety of public drug use, according to the Drug Administration Law and relevant laws and regulations and the drug sampling plan of Jiangxi Province, drug regulatory departments and inspection agencies at all levels in our province have carried out supervision and sampling of drug production, operation and use units throughout the province.
The current issue of drug sampling information is reported as follows: First, the announcement: After verification and confirmation, the current period of supervision sampling information published as follows: 15 varieties of 18 batches do not meet the standard provisions (see annex), non-compliance with the provisions of the items including characteristics, inspection, content determination and so on.
II. The investigation and prosecution of non-compliant drugs The Jiangxi Provincial Drug Administration has tasked the relevant departments to take necessary control measures such as seizure, seizure, suspension of sales and recall of non-compliant drugs for inspection, and to investigate and punish the production enterprises and the sampling units in accordance with relevant laws and regulations.
Annex: Summary of Information on Drug Supervision and Sampling Non-Compliance (No. 1 of 2021).xlsx Jiangxi Provincial Drug Administration January 6, 2021 (Public Attributes: Active Disclosure) Source: Jiangxi Provincial Drug Administration
